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Mass spectrometry imaging (MSI) is a powerful analytical method for the 
simultaneous analysis of hundreds of compounds within a biological sample. 
Despite the broad applicability of this technique, there is a critical need for 
advancements in methods for small molecule detection. Some molecular classes 
of small molecules are more difficult than others to ionize, e.g., neurotransmit-
ters (NTs). The chemical structure of NTs (i.e., primary, secondary, and tertiary 
amines) affects ionization and has been a noted difficulty in the literature. In order 
to achieve detection of NTs using MSI, strategies must focus on either changing 
the chemistry of target molecules to aid in detection or focus on new methods of 
ionization. Additionally, even with new strategies, the issues of delocalization, 
chemical background noise, and ability to achieve high throughput (HTP) must be 
considered. This chapter will explore previous and up-and-coming techniques for 
maximizing the detection of NTs.
Keywords: mass spectrometry imaging, neurotransmitters, gold nanoparticles, 
derivatization, sample preparation
1. Introduction
Mass Spectrometry Imaging (MSI) is an incredibly powerful label-free tech-
nique that can determine qualitative and quantitative information of hundreds of 
compounds in a tissue section in one experiment [1, 2]. Small molecule detection, 
especially of neurotransmitters (NTs), currently relies heavily on histochemical, 
immunohistochemical, and ligand-based assays. Antibody-based methods suffer 
from limitations in cost and availability of antibodies, lack of specificity for target 
molecules of interest, and low throughput [3, 4]. The development of MSI has 
overcome many of these challenges and will be discussed throughout. The basic 
methodology of MSI is to section tissue using a cryostat to approximately 10-20 μm 
thickness; tissues may or may not be embedded in a cryomatrix such as Shandon™ 
M-1 (ThermoFisher Scientific). Next, matrix must be deposited on the tissue 
section, which is most often done by spray-coating the tissue using a pneumatic 
sprayer. Variations on typical organic matrices, such as inorganic nanoparticles 
(NPs), have been explored by numerous researchers and will be commented on 
here. Mass spectral data is collected at discrete locations on the sample surface via 
a raster pattern, which can then be assembled into a heat-map image of molecule 
location. Figure 1 depicts the typical MSI scheme [5]. A number of overall reviews 
of MSI have appeared in recent years [6] that address broad topics like ionization of 
small molecules [7], clinical applications [2], and high-resolution analyses [5].
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The broader scientific community is not yet fully utilizing MSI as there are still 
challenges to be overcome [7, 8], including: (i) low ionization efficiency for small 
molecules, (ii) chemical noise interferents/overlapping signals of small molecules 
with traditional matrices [9], (iii) reproducibility issues across laboratories which 
limits universal procedures for MSI in pre-/clinical research, (iv) limits to lateral 
spatial resolution inherent to the matrix crystallization process which affects the 
ability to clearly define tissue margins, and (v) delocalization of analyte mol-
ecules during sample preparation. This chapter will focus on the analysis of small 
molecules, specifically neurotransmitters (NTs), due to the complex biological 
processes that occur in the brain and have broad implications in disease states and 
overall health. This chapter is broken down in two main categories, as strategies to 
improve ionization must either focus on (i) the chemical nature of the analyte and 
changing its properties to better facilitate ionization, or (ii) on utilizing a different 
mechanism of ionization to favor small molecules of interest.
2. Small molecule basics for MSI
Small molecule NTs are the chemical messengers of the central nervous system. 
Having a complete picture of NT location and abundance will aid in understanding 
of many different disease states and developmental processes. NTs are difficult to 
detect in situ via mass spectrometry due to their low physiological abundance (e.g., 
nM to pM concentration) within a complex biological tissue with many different 
classes of biomolecules, and overlapping low molecular mass range with most 
traditional matrices. Prior to the analyses discussed here, NTs were localized based 
on their protein-receptors or transporters, which does not always give an accurate 
accounting of present location.
Instrumentation used for MSI can vary widely, but most laser-based work 
is performed by time-of-flight (TOF) instruments. The other common setup is 
using desorption electrospray ionization (DESI) as an ion source, which is not the 
focus here, but is another option gaining in popularity [10, 11]. Other hardware 
Figure 1. 
General scheme of the mass spectrometry imaging process. (a) The tissue section is covered with matrix and 
irradiated by a pulsed laser beam. (b) Mass spectrum acquired from one spatial location on the tissue section. 
(c) MS images of different m/z peaks compiled from all spatial locations. Reprinted with permission from  
Ref. [5]. Copyright 2013 Springer.
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configurations can favor small molecules (e.g., ion mobility, triple quadrupole 
instruments, Fourier transform – ion cyclotron resonance) and so there is no one-
size-fits-all set-up for small molecule MSI experiments. In contrast to instrument 
choice, sample preparation/derivatization and ionization conditions are areas that 
can be standardized in order to achieve similar results across different platforms. 
The focus here is not on the many instrument combinations as other reviews have 
adequately explored this topic [6, 7].
Sample handling and preparation of tissue sections are integral to maintaining 
sample integrity; after cryo-sectioning, tissue is typically thaw mounted onto a solid 
surface. The surface must be conductive in order to apply a potential to the sample 
and accelerate ions out of the instrument source. Common materials include coated 
metal targets (expensive, cannot be archived, and not histology compatible) or 
indium-tin oxide (ITO) coated glass slides. Matrix application to the tissue section 
is ideally a homogenous coating of small crystals that provide optimum extraction 
conditions of analyte. After application, the key process is the co-crystallization 
that must occur between matrix and analyte. Spraying parameters affect the “wet-
ness” of the surface of the tissue and are a balance between molecular diffusion and 
effective extraction. Crystal size is one of the more critical factors for a successful 
MSI experiment and multiple studies determined the parameters important for 
optimum crystallization.
Commonly used organic acid matrices for MSI are shown in Table 1 and 
include sinapinic acid (SA), 2,5-dihydroxybenzoic acid (DHB), and α-cyano-
4-hydroxycinnamic acid (CHCA). These matrices work for a broad variety of 
biomolecules including peptides and lipids, but do not always translate well to 
small molecule detection. The introduction of N-(1-napthyl)ethylenediamine 
dihydrochloride (NEDC) and 1,5-diaminonapthalene (DAN) have improved the 
detection of small molecules, though these matrices have different preparation 
needs (e.g., sublimation and recrystallization) which increases the time required for 
sample processing [12, 19]. DAN and NEDC matrices have not been fully explored 
yet in the literature. Moreover, the propensity for organic matrices to self-ionize 
and create chemical noise in the low mass range prevents effective analysis of most 
metabolites. Recently, this has led toward the rational design [35] or selection [36] 
of matrices that can address this, but the lack of consistency in performance can 
still be an issue. Matrix applications are notorious for behaving differently across 
laboratories, and significant research in the past 25 years has been devoted to identi-
fying preparation methods that result in the most consistent data [37–39].
Sublimation procedures, mentioned vida supra, require that matrix and sample are 
placed in a vacuum chamber which is evacuated [32]. The sample is cooled while the 
matrix is heated, resulting in sublimation of the matrix which will condense on the cool 
sample surface. Recrystallization of the matrix is often coupled with this technique. 
There are advantages and disadvantages to all of the aforementioned matrix applica-
tion techniques, which have been discussed thoroughly in the literature [40–42]. 
Automated sprayers have become increasingly popular and help with consistency of 
matrix application, though the size and spacing of the matrix droplets will ultimately 
affect spatial resolution of the experiment. This topic has been frequently discussed 
and reviewed in the literature [2, 6], so only a basic introduction is given here.
Despite these challenges, there are a few examples of successful metabolomics 
imaging experiments, though they have utilized purposefully designed matrices 
that do not generate interfering signals [35] or have used high-resolution instru-
ments that have the high mass accuracy to distinguish between isobaric signals 
[43, 44]. These approaches are not an all-encompassing solution, and the next 
sections explore other strategies to achieve broader success with MSI of small 
molecules, specifically NTs.
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3. Alternative matrix materials
As an alternative to the traditional organic acid matrices, contemporary stud-
ies have returned to the inorganic materials that were originally proposed for 
MALDI-MS by Tanaka et al. [45]. Nanoparticles (NPs) made of gold [46–49], silver 
[50–53], carbon based substrates [54–57], and silicon surfaces [58, 59] have been 
demonstrated on the target plate as materials that facilitate ionization of biomol-
ecules. In particular, gold NPs (AuNPs) have the potential to be a more universal 
material to help facilitate ionization of small molecules and seem to have fewer 
reproducibility issues across multiple instrument platforms, locations, and organ-
isms/biofluids [46, 60, 61]. Specific advantages for ionization of small molecules 
using AuNPs on the target plate include: (i) less chemical noise in the range where 
small molecules are found (below m/z 300), (ii) flexible analyte solution prepara-
tion conditions, including tolerances for salts, surfactants, and pH, and (iii) broad 
applicability across chemical classes [46, 48, 57, 60, 62].
The general success, though not broad usage, of these materials on the target 
plate have led to several different approaches for using alternative inorganic 
Matrix and structure Common analytes
Sinapinic acid (SA) Proteins [12–15]
2,5-dihydroxybenzoic acid (DHB) Peptides [16–18], lipids [19, 20], 
some small molecules [4, 21, 22]
α-cyano-4-hydroxycinnamic acid (CHCA) Neuropeptides [23], peptides [24], 
proteins [25], lipids [26, 27],  
drugs [28]
N-(1-napthyl)ethylenediamine dihydrochloride (NEDC)• 2HCl Small molecule metabolites [29], 
lipids [30]
1,5-diaminonapthalene (DAN) Lipids [31–33], small molecule 
metabolites [34]
Table 1. 
Common MSI organic acid matrices and their applications.
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materials for MSI, such as sputtering of metals or the use of metallic NPs, both of 
which are described in the paragraphs below.
Sputtering of metals over tissue sections has produced a number of quality 
articles that have utilized silver [50], platinum [63], and gold [64]. Sputtering 
deposits highly pure and homogeneous metal or metal oxide nanolayers onto 
biological tissue sections. Magnetron sputtering systems utilize a plasma gun 
under high- or ultra-high vacuum and deposits layers of metal onto the substrate 
of interest. Deposition times range from under a minute to several minutes, with 
total sample preparation time at least several minutes long because of the need for 
a vacuum-based system. Sputtered layers of silver or gold are typically reported in 
the 20-50 nm range [49, 50, 65], which is a narrower size distribution than solution-
based NPs. The biggest disadvantages of sputtering are the need for expert users, 
the time involved for sample preparation, and the equipment cost (e.g., sputtering 
apparatuses are up to tenfold more expensive than pneumatic sprayers).
Molecules that have been successfully detected using Ag or Au sputtering 
experiments are largely neutral lipids, with cholesterol being of high interest 
[49, 50, 52, 66]. Pt sputtering has been demonstrated on lipids in tissue [67] 
and in leaves where metabolites of interest were detected, including many with 
molecular features similar to NTs, such as acetamiprid [63]. Rafols et al. showed 
an Au sputtering MSI experiment that resulted in the potential detection of 
25 different compounds, but only 1 of which could be called a small molecule 
metabolite (i.e., citrulline) [64]. A significant advantage that sputtering dem-
onstrates, compared to organic acid matrices [22], is the lack of analyte delocal-
ization [64]. The largest survey of sputtering materials was done by Hansen et 
al., where Ag, Au, Cu, Ni, Pt, and Ti were sputtered for varying times on plant 
tissues [68]. Noble metals (e.g., Ag, Au, Pt) were found to be more effective than 
transition metals (e.g., Cu, Ni, Ti) for overall ionization in positive- and nega-
tive-ion modes. While lipids were the most prevalent biomolecule class exam-
ined, this is a rare demonstration of the detection of amine-based structures, 
including choline, asparagine, glutamic acid, and leucine. DHB was used for 
comparison in positive-ion mode and DAN in negative-ion mode, with primarily 
insoluble lipids being effectively ionized with organic matrices. A summary of 
the molecules detected is shown in Figure 2.
Nanomaterials in suspension form, such as colloidal NPs, could potentially 
be deposited or sprayed onto tissue sections for analysis, yet there are only select 
demonstrations of this application for MSI, which are described herein. This area of 
research has again been applied primarily to lipidomics, with successful detection 
of fatty acids and their derivatives, sterols, phospholipids (e.g., phosphatidyletha-
nolamine, phosphatidylcholine, phosphatidylinositol, etc.), sphingomyelins, and 
ceramides. Silver NPs (AgNPs), including those that have been surface-derivatized 
are most popular. Polyvinylpyrrolidone-capped AgNPs have been utilized for 
analysis of brain [69], and AuNPs with alkylamine surface modifications have been 
used for imaging of glycosphingolipids in the brain [70]. Fluorinated AuNPs have 
been shown to detect carbohydrates, lipids, bile acids, sulfur metabolites, amino 
acids, nucleotide precursors, and more in mouse colon [71].
Small molecule examples, specifically NTs, are notably lacking in the MSI 
literature. We have been developing a method for the detection of endogenous NTs 
from biological samples using citrate-capped AuNPs that are pneumatically sprayed 
on tissue sections [47]. Successful detection of acetylcholine, dopamine/octopa-
mine, epinephrine, glutamine, GABA, norepinephrine, and serotonin was achieved 
in rabbit brain tissue sections, zebrafish embryos, and neuroblastoma cells [61, 72]. 
See Figure 3 for an image of seven different NTs in 5 day-post fertilization zebrafish 
embryos.
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With the intention of demonstrating the flexibility of AuNPs in terms of 
sample preparation, spraying parameters have been explored, including matrix 
concentration, solvent composition, spray temperature, and linear flow rate (which 
determines overall spray density of material). Early data and statistical analysis by 
principal component analysis (PCA) suggests that: (i) AuNP concentration can be 
varied over 4 orders of magnitude, (ii) a variety of organic:aqueous solvent mixes 
are possible, and (iii) temperatures from 30 to 60°C can be utilized [73, 74]. The 
flexibility in spray parameters means that less-experienced users with varying 
spraying capabilities can still get optimum data from their tissue sections, opening 
the application of MSI to more areas of study.
As previously mentioned, delocalization is an issue with organic acid matrices, 
often because of a “wet” matrix spray that results in true molecular diffusion 
instead of analyte extraction from the tissue. A standard literature method for 
CHCA has been compared with AuNPs, where CHCA gives only extreme delocal-
ization outside of the tissue margins, and the AuNPs result in distinct anatomical 
visualization, as well as the ability to see subtle differences in analyte concentration 
[61]. Another advantage of AuNPs that we have discovered is flexibility in sample 
storage. For example, AuNP-sprayed tissue sections on slides were stored overnight 
at −20°C and imaging runs were repeated after 24 hours. Nearly identical data 
resulted and up to 8 imaging runs were completed on the same tissue section with-
out loss of signal or the need to reapply AuNPs. The ability to archive slides for later 
Figure 2. 
Summary of sputter-coated metal screening for small metabolite analysis in (a) positive and (b) negative ion 
mode. Asterisks indicate a fragment ion was detected. Reprinted with permission from Ref. [68]. Copyright 
2018 American Society for Mass Spectrometry.
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examination could allow for follow-up data to be collected as well as the potential to 
reduce the number of organisms needed in a given research project.
The improvements in delocalization, reproducibility, and long-term stability 
from pneumatically-sprayed AuNPs warrant further investigation of this method. 
Finally, the quick and low-cost preparation may enable a broad range of new appli-
cations in neuroscience, pharmacology, drug discovery, and pathology.
4. Derivatization strategies
Chemical derivatization of functional groups is a common strategy to improve 
detection in MS techniques for a variety of molecular classes. On-tissue derivatiza-
tion has been explored for many different purposes, including tryptic digestion 
[75, 76], phospholipid digestion [77], N-terminal peptide derivatization [78], and 
Figure 3. 
MSI of a sagittal zebrafish tissue section at 5 μm lateral spatial resolution with eye (E), forebrain (FB), 
midbrain (MB), and hindbrain (HB) indicated in (a), (b) is the [GABA + Na]+ image, (c) is the epinephrine 
image, (d) is the histidine image, (e) is the acetylcholine image, (f) is the glutamine image, (g) is the 
dopamine/octopamine image, (h) is the norepinephrine image, and (i) is the serotonin image. Reprinted with 
permission from Ref. [61]. Copyright 2020 American Chemical Society.
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Figure 4. 
(a) Reaction of dopamine with pyrylium salts. MALDI-MSI images of dopamine derivatized with DPP (b, c),  
PBDPP (d, e) or TMP (f, g). Signal intensity is indicated using a rainbow scale. Reprinted with permission 
from Ref. [84]. Copyright 2015 American Society for Mass Spectrometry.
derivatization of various metabolites/drugs of interest [79–82]. One particularly 
attractive advantage of derivatization is that small mass species typically have a 
change in molecular weight which avoids interferences from low mass matrix peaks.
Some of the aforementioned studies were on small molecular weight species, 
but derivatization was typically for only one analyte of interest. Examples of NT 
derivatization have met with varied success in terms of how many different molecu-
lar classes are accessible. Coniferyl aldehyde has been used to derivatize primary 
amines in pig adrenal glands and rat brains [83]. Methods included pre-coating 
target plates and then incubating after tissue was affixed for several minutes. Spray-
coating with an organic matrix followed.
Specific reactions focused on NTs have utilized pyrylium salts (e.g., 2,4-diphenyl 
pyranylium (DPP)) that are reactive toward primary amines. The reaction scheme 
with a common NT, dopamine, is shown in Figure 4a. The reaction can proceed at 
room temperature but requires 30-80 spray passes of the derivatizing agent, fol-
lowed by drying time, and then application of an organic matrix [84]. Additionally, 
preparation of the derivatizing agent is required and can be a multi-day process. 
While smaller crystals than typical organic matrix preparations have been reported, 
there are still limitations on overall spatial resolution. Figure 4b shows dopamine 
derivatized with 3 different pyrylium salts and the resulting images that are gener-
ated; without derivatization no dopamine was observed.
Derivatization with DPP has been demonstrated in multiple instances, with the 
generation a 3D mouse brain atlas of dopamine, norepinephrine and serotonin [85] 
as well as detection of up to 23 amino metabolites [86].
Additional derivatization methods have been developed since the initial report 
on primary amines only. For example, fluoromethylpyridinium-based materials 
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are reactive with phenolic hydroxyl and/or primary or secondary amines, which 
expand the potential range of NTs that can be detected [87]. Charge-tagging 
using 2-(4-bromophenyl)-4,6- diphenylpyranylium (Br-TPP) results in distinctive 
isotopic distributions in the mass spectrum, making it easier to identify derivatized 
species from other potential species [88].
The last example here is a laser-induced tissue transfer (LATT) system that 
enhances on-tissue derivatization of small molecules [89]. An electrosprayer applies 
the derivatization reagent and matrix solution on tissue and is then irradiated with a 
450 nm laser beam in transmission mode, which results in transfer of a thin film of 
tissue to a second slide. Figure 5 shows the setup and diagram of the LATT system. 
Chemicals used for derivatization include coniferyl acetate or Girard’s T reagent. 
Preparation time requires multiple hours (overnight) and additional matrix appli-
cation. Multiple classes of biomolecules were analyzed, including amino acids, NTs, 
polyamines, dipeptides, and others. The issue of analyte delocalization is improved 
in LATT as compared to other derivatization techniques.
5. Quantitation
MSI has been applied to quantitative analysis of drugs [90, 91], metabolites [92], 
and biomarkers in tissue [93] using pneumatic sprayers and sublimation techniques 
described in this chapter. Nearly all of these demonstrations have utilized organic 
acid matrices such as DHB, CHCA, and trihydroxyacetophenone (THAP), with one 
research group utilizing TiO2 NPs [94, 95]. Methods of quantitation are still being 
investigated [96], as many of the consistency issues with MALDI-MSI that have 
been discussed in this chapter are even more relevant with quantitative MSI (qMSI). 
Figure 6 shows a summary of two of the more common methods used for genera-
tion of a calibration curve for qMSI, on-tissue spotting and tissue mimetic models 
which feature spiking of tissue homogenates [96].
On-tissue spotting uses either a standard molecule that is chemically similar 
to the analyte or a stable isotope of the analyte for making the calibration curve. 
Ion intensities between the analyte and standard are used to estimate the drug 
concentration in dosed tissue. Disadvantages include difficulty in maintaining 
uniform application of standards and differences in ionization for sprayed on 
standards vs. analyte molecules embedded within tissue. Advantages are that this 
method is fast and straightforward. The tissue mimetic model uses a surrogate 
tissue that is homogenized and spiked with the analyte of interest, frozen, sec-
tioned, then prepared with matrix. The advantage of this method is that there is 
Figure 5. 
(A) LATT setup and (B) schematic diagram of the system. Reprinted with permission from Ref. [89]. 
Copyright 2020 American Chemical Society.
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better representation of the ionization process for analyte embedded within tissue. 
However, it is more time consuming, labor intensive, and requires more tissue for 
the calibration curve. Each method has been correlated with LC-MS data, the cur-
rent primary method used for quantification [97].
Specific examples with clinical relevancy are briefly described here. First, eper-
tinib and lapatinib were quantified in a metastatic brain cancer mouse model using 
stable isotope labeling, and with liquid chromatography (LC)-MS validation [91]. 
The topical drugs roflumilast, tofacitinib, ruxolitinib, and LEO 29102 were examined 
in human skin explants to determine drug penetration and evaluate lipid markers 
[90]. qMSI data had a much lower quantitation range than LC-MS data of individual 
skin layers. Rifampicin in mouse liver tissue was quantified via a fragment ion of the 
intact molecule. The method used an in-house synthesized stable isotope and cor-
related the results with LC-MS/MS [98]. Lastly, there is one example that specifically 
focused on comprehensive mapping of NTs in Parkinson’s disease lesioned mouse 
brain and demonstrated quantitation of dopamine using a stable isotope [87]. All of 
the drug molecules listed in this paragraph are above the general size range that NTs 
and metabolites fall within, ranging from 400 to 800 Da, but present possible future 
avenues of research for the NT-focused methods discussed in this chapter.
The tissue mimetic model first gained popularity with examination of lapatinib 
and nevirapine in mouse liver by Groseclose and Castellino [99]. In addition to 
demonstrating high spatial resolution, they examined reproducibility and drug 
distribution within the homogenate. Fewer applications of the tissue mimetic 
model have been done, especially with small molecules as opposed to lipids [100]. 
A notable example includes the determination of the spatial distribution of gem-
citabine, a chemotherapeutic agent, and its metabolites in mouse model pancreatic 
tumors using AuNPs and a traditional matrix as comparison [101]. Further experi-
ments also work on the computational side of MSI and determining the best ways to 
normalize spectra [102, 103].
6. Concluding remarks
This chapter has introduced the utility of mass spectrometry imaging (MSI) for 
small molecules, with a specific focus on neurotransmitters (NTs). Methods that 
have resulted in enhanced signals of NTs were highlighted, with alternative matrix 
materials and chemical derivatization of analytes the two main points of discussion. 
Future research is needed in both of these areas to determine optimum conditions 
and applications, as well as establishing standard procedures so that broad applica-
tion of MSI can continue. Finally, an area not discussed here that is relevant to these 
Figure 6. 
Description of qMSI experiments where on-tissue spotting and homogenate spiking are two popular methods. 
Reprinted with permission from Ref. [94]. Copyright 2019 Elsevier Ltd.
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techniques and that will likely be explored in the future is the quantitative determi-
nation of small molecules.
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